Maraviroc Plus Atazanavir/r Without Nukes Versus Standard of Care: 48-Week Results - The Body
Links shared publicly online about this topic.
- 28total visits
Maraviroc Plus Atazanavir/r Without Nukes Versus Standard of Care: 48-Week Results - The Body
Updated results from a Pfizer-sponsored study of dual therapy maraviroc plus atazanavir/r compared to standard of care atazanavir/r plus tenofovir/FTC ...
View full resource at thebody.com
Tags: HIV, AIDS, HIV Medication, STD, Selzentry
Most Recently Shared on September 2, 2011 at 12:00 pm By:
IAS 2011: Maraviroc Plus Atazanavir/r Without Nukes Versus Standard of Care: 48-Week Results http://t.co/Oy3XioE #ias2011 #hiv #aids
Advertisement
